This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Prelude Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hal K Berman: Innovator in Cancer Biomarkers
Introduction
Hal K Berman is a notable inventor based in the United States, recognized for his contributions to the field of cancer research. His work primarily focuses on the development of cancer biomarkers and methods for their use. Although he holds no patents, his research has significant implications for understanding and predicting cancer risks.
Latest Patents
One of Hal K Berman's key contributions is the patent titled "Cancer Biomarkers And Methods Of Use Thereof." This patent provides embodiments for characterizing a biological sample. In particular, it allows for the estimation of the risk that a subject with ductal carcinoma in situ will experience subsequent DCIS events and/or invasive cancers.
Career Highlights
Throughout his career, Hal K Berman has worked with various organizations, including Prelude Corporation and the University of California. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
One of his notable coworkers is Thea D Tlsty, with whom he has likely shared insights and advancements in cancer biomarker research.
Conclusion
Hal K Berman's work in cancer biomarkers represents a significant step forward in the understanding of cancer risks and patient outcomes. His contributions continue to influence the field of cancer research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile